Who is the assignee on this patent?

Chang Yun Sil, Park Won Soon, Yang Yoon-Sun, and 2 more

What technology area does this patent fall under?

Primary CPC classification A61K35/28. Mapped technology areas include Human Necessities.

When was this patent published?

Publication date Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Method of treating lung diseases using cells separated or proliferated from umbilical cord blood

US9498497B2 · US · B2

Patent metadata
Field	Value
Publication number	US-9498497-B2
Application number	US-18469508-A
Country	US
Kind code	B2
Filing date	Aug 1, 2008
Priority date	Feb 1, 2006
Publication date	Nov 22, 2016
Grant date	Nov 22, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There is provided a method of treating lung diseases including administering cells separated or proliferated from umbilical cord blood to a patient suffering from such diseases.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of treating bronchopulmonary dysplasia (BPD) in an infant or premature baby in need thereof, comprising intratracheal administration of a composition comprising a therapeutically effective amount of umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) to the infant or premature baby. 2. The method of claim 1 , wherein said composition comprises 1.0×10 5 cells/ml to 1.0×10 9 cells/ml.

Assignees

Inventors

Classifications

A61P43/00
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
A61K35/28Primary
Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells · CPC title
A61K35/16
Blood plasma; Blood serum (umbilical cord blood A61K35/51) · CPC title
A61K45/06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
A61K35/51
Umbilical cord; Umbilical cord blood; Umbilical stem cells · CPC title

Patent family

Related publications grouped by family.

View patent family 38322300

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9498497B2 cover?: There is provided a method of treating lung diseases including administering cells separated or proliferated from umbilical cord blood to a patient suffering from such diseases.
Who is the assignee on this patent?: Chang Yun Sil, Park Won Soon, Yang Yoon-Sun, and 2 more
What technology area does this patent fall under?: Primary CPC classification A61K35/28. Mapped technology areas include Human Necessities.
When was this patent published?: Publication date Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).